Lecanemab Trial Data Gives Hope to Alzheimer’s Community

Promising new data released today indicate that help could soon be on the way for people living in the early stages of Alzheimer’s.

Faith in Action Campaign Launches to Promote Brain Health Among Black Americans

In partnership with The Alter Program and national faith leaders, UsAgainstAlzheimer’s is launching Faith in Action, an initiative bringing free culturally tailored brain health information and resources to the pews of more than 30 churches, with an emphasis on Georgia.

The Brain Health Academy

Free, evidence-based courses to equip healthcare and wellness providers with the knowledge and resources to help people reduce the risk of dementia and Alzheimer’s.

Say Hello to BrainGuide

Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials.

Lecanemab Trial Data Gives Hope to Alzheimer’s Community

Faith in Action Campaign Launches to Promote Brain Health Among Black Americans

The Brain Health Academy

Say Hello to BrainGuide

Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • January 27, 2022

    UsAgainstAlzheimer’s Welcomes Biogen’s 18 Percent Diversity Goal for U.S. Participants in Aduhelm Confirmatory Trial

    “This is an important step forward in ensuring that people of color...

    Read more
  • January 26, 2022

    UsAgainstAlzheimer’s Letter to HHS Secretary Becerra: Direct CMS to Reconsider its Draft Decision on Medicare Coverage for Alzheimer’s Drugs

    Patient advocacy group UsAgainstAlzheimer’s today urged Health and Human Services Secretary Xavier...

    Read more
  • January 19, 2022

    Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

    With so much misinformation surrounding the draft National Coverage Determination (NCD) from...

    Read more
  • January 13, 2022

    New Guidance Provides Clinical Recommendations to Reduce Dementia Risk

    Today, Primary Prevention Recommendations to Reduce the Risk of Cognitive Decline...

    Read more
  • January 12, 2022

    Medicare Slams the Door on Alzheimer’s Treatments

    The Centers for Medicare and Medicaid Services (CMS) announced today that it...

    Read more
  • January 10, 2022

    UsAgainstAlzheimer’s Applauds HHS Secretary Becerra for Calling on Medicare to Reexamine its Planned Premium Increase

    Just weeks after UsAgainstAlzheimer’s urged Health and Human Services Secretary Xavier Becerra...

    Read more


  • Resources

    A-LIST Pulse of the Community – November 2022

  • Resources
    Us Against Alzheimer's 2021 Annual Report

    2021 Annual Report

    With breakthroughs in treatment, a remarkable step forward in prevention, and a new initiative to raise public awareness of the importance of brain health, many efforts were led by UsAgainstAlzheimer’s...

  • Resources
    A-List 2017-2022 surveys

    A-List What Matters Most Surveys

    A-List 2017-2022 surveys, updated July 2022